FUNPAMUS: Functional Pathologies of the Musculoskeletal System in Physiotherapy Students

Sponsor
Charles University, Czech Republic (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05544188
Collaborator
(none)
60
2
16

Study Details

Study Description

Brief Summary

This study map the occurrence of functional pathologies of the musculoskeletal system in students of the bachelor's program of physiotherapy of the Third Faculty of Medicine, Charles University, and aim on improvement of them.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Differential diagnostic
N/A

Detailed Description

The aim of this study is to map the occurrence of functional pathologies of the musculoskeletal system in students of the bachelor's program of physiotherapy of the Third Faculty of Medicine, Charles University, and to examine their postural functions. Another goal is to teach the students of the experimental group how to remove functional pathologies of the musculoskeletal system and how to change their motor behaviour and postural functions so that the development of functional disorders no longer occurs.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Screening
Official Title:
Occurrence and Characteristics of Functional Pathologies of the Musculoskeletal System in Physiotherapy Students and the Possibility of Influencing Them
Anticipated Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
Nov 30, 2023
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: individual outpatient physiotherapy

individual outpatient physiotherapy (7 times in two and a half months, approx. 90 minutes) aimed at correcting functional pathologies of the musculoskeletal system assessed by differential diagnosis (removal of trigger points, stretching of shortened muscles and mobilization of joint blockages) and changing of motor program that led to the occurrence of the functional disorder by means of Motor Programmes Activating Therapy

Diagnostic Test: Differential diagnostic
Physiotherapy aimed at correcting functional pathologies of the musculoskeletal system assessed by differential diagnosis (removal of trigger points, stretching of shortened muscles and mobilization of joint blockages)

Active Comparator: Without changing the current habits

It will not change the existing habits. At the same time, however, these are physiotherapy students who will participate in the classes. Their motor behaviour can thus be influenced in a natural way.

Diagnostic Test: Differential diagnostic
Physiotherapy aimed at correcting functional pathologies of the musculoskeletal system assessed by differential diagnosis (removal of trigger points, stretching of shortened muscles and mobilization of joint blockages)

Outcome Measures

Primary Outcome Measures

  1. Changes in Trigger Points at 3 months [Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months).]

    Local hypertonic change in muscle function arising as a manifestation of pathogenic tension, 0 no trigger point, 2 maximal tiger point (higher value, worse function)

Secondary Outcome Measures

  1. Change in the Foot posture index at 3 and 15 month [Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).]

    Clinical examination of the foot type ranging from significantly pronated (values 6 - 12) to significantly supinated (values from -1 to -12) one according to the 6-item, higher value (both negative or positive) means worse function.

  2. Change in Foot morphology and flexibility at 3 and 15 month [Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).]

    examination by means of the full foot 3D scanner Footscan® and the software 3D scanner 7.7 while sitting and standing still. Arch high index defines two kinds of pathologies: hypermobility under 0,6, norm 0,7 - 0,8, rigidity 0,9 - 1,3

  3. Change in Postural stability at 3 and 15 month [Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).]

    evaluation of the level of postural stability using the total path of displacement of the centre of pressure of the body on the mat in mm and the maximum displacement obtained in the latero-lateral and in the anteroposterior direction in mm (lower number means better function), measurement using the RS Footscan® tensiometric plate, higher value means worse function.

  4. Change in the subtalar joint flexibility at 3 and 15 month [Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).]

    mobility of the subtalar joint during the initial phase of walking (software evaluation after walking barefoot on the Footscan® tensiometric plate). Under 5.5° means normal range of pronation and normal function. Higher values mean worse function and pathologic pronation during initial phase of gait.

  5. Change in the foot progression angle at 3 and 15 month [Pre-assessment (baseline testing), Post-assessment (immediately after the end of three months), Follow up (at 15 months).]

    rotation of the foot during walking (software evaluation after walking barefoot on the Footscan® tensiometric plate). Normal angle 0-5.4°, in-toeing (inwards rotation) under 0°, out-toeing (outward rotation) above 5.5°.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Bachelor's study of physiotherapy at the Third Faculty of Medicine, Charles University

  • The presence of functional pathologies of the musculoskeletal system (verification by means of Trigger Points)

Exclusion Criteria:
  • Serious cardiovascular or orthopedic dysfunction

  • Neurological disease

  • Reduced cognitive functions complicating examination and subsequent therapy

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Charles University, Czech Republic

Investigators

  • Principal Investigator: Kamila Rasova, Third Faculty of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kamila Řasová, doc. PhDr. Kamila Řasová, PhD., Charles University, Czech Republic
ClinicalTrials.gov Identifier:
NCT05544188
Other Study ID Numbers:
  • 29072022
First Posted:
Sep 16, 2022
Last Update Posted:
Sep 16, 2022
Last Verified:
Sep 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kamila Řasová, doc. PhDr. Kamila Řasová, PhD., Charles University, Czech Republic
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 16, 2022